Capital Performance Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,944
Closed -$56.1K 319
2024
Q3
$56.1K Buy
+1,944
New +$56.1K 0.02% 319